Living With Type 2 Diabetes: Honest Lessons From People Who've Been There

A type 2 diagnosis usually arrives in a ten-minute appointment, often as a surprise, sometimes from a blood test taken for something else entirely. What people describe afterwards is a long, quiet, self-managed condition that nobody supervises very closely and that they were expected to understand almost immediately. What follows is drawn from first-person accounts, alongside current NICE and NHS guidance. It is companion reading, not medical advice, and nothing here should be used to change medication or start a restricted diet without your clinical team.

The diagnosis lands harder than clinicians expect

The most consistent theme in these accounts is a mismatch of scale. To the clinician it is a common, manageable, well-understood condition. To the person on the other side of the desk it is frequently shame.

Contributors describe shame with unusual frankness. Type 2 diabetes carries a public narrative about self-inflicted illness that other conditions do not, and people describe absorbing it completely: not telling colleagues, not telling extended family, eating differently in private than in company. Several describe a first reaction of "I did this to myself" before any consideration of genetics, ethnicity, medication history, age, or the long list of factors that had nothing to do with them.

People also describe the opposite reaction, which comes up almost as often: nothing. No symptoms, no pain, a number on a page, and a strong instinct that it could not really be serious. Accounts from people who lost years to that instinct are among the most sobering in these collections.

Learning to live with a number

HbA1c is the measure most people become fixated on. It reflects average blood glucose over roughly the preceding two to three months, and because it is checked at long intervals, people describe an unusual relationship with it: months of effort compressed into a single result delivered by text message.

Two patterns emerge. Some describe it as motivating, a scoreboard that made abstract effort concrete. Others describe it as punishing, a periodic verdict on their character, particularly when the number moved the wrong way for reasons they could not identify. Contributors frequently note that stress, illness, poor sleep and certain medications move blood glucose independently of anything they ate, which nobody had told them.

The other recurring observation is that targets are individual. People describe comparing their number to somebody else's on a forum and despairing, without knowing that the other person's target had been set differently for entirely sound clinical reasons — age, other conditions, and the risk of hypoglycaemia all factor in.

Remission is real, and it is more specific than the internet suggests

This is the area where accounts most often collide with misinformation, so it is worth being precise.

Remission of type 2 diabetes is a recognised clinical outcome, generally defined in the UK as HbA1c below the diabetic threshold sustained for at least three months without glucose-lowering medication. It is not a cure, and it is not permanent by definition; the condition can return.

The evidence base most people are indirectly referring to is the DiRECT trial, funded by Diabetes UK and run in Scottish and Tyneside general practices. It recruited people diagnosed within the previous six years and used a supervised programme: a total diet replacement of roughly 800 calories a day for three to five months, with diabetes and blood pressure medication withdrawn by the clinical team at the outset, followed by structured food reintroduction and long-term maintenance support. Almost half of participants were in remission at twelve months, and more than a third remained in remission at two years. Remission tracked closely with how much weight was lost and kept off.

Three points that get lost in the retelling. The programme was medically supervised and involved stopping medication under supervision, which is not something to replicate alone. Participants were relatively recently diagnosed, and the likelihood of remission falls as duration increases. And the hard part was not the three months of the diet but the years of maintenance afterwards.

In England this now exists as a referral route: the NHS Type 2 Diabetes Path to Remission Programme. Whether you are eligible is a question for your GP or diabetes team.

Diabetes distress is not the same as depression

A concept that appears constantly in these accounts, usually without a name attached, is diabetes distress: the specific exhaustion of managing a condition that never takes a day off and never announces progress.

People describe burnout rather than sadness. Skipping the monitoring for a fortnight. Eating what they wanted out of sheer fatigue with deciding. Not booking the annual review because they knew the number would be bad and could not face being told. This last one comes up so often it is worth naming plainly: people avoid appointments precisely when they most need them, out of anticipated shame.

It is a recognised phenomenon, distinct from clinical depression, and diabetes teams are used to it. Contributors who raised it describe the relief of being met with a plan rather than a lecture.

The checks people skip, and later wish they had not

Type 2 diabetes damage accumulates silently in small blood vessels and nerves. The annual review structure exists because the complications are far easier to prevent than to reverse.

Eye screening comes up most. Retinopathy is asymptomatic in its early stages, which means the first thing you notice can already be significant. Contributors who lost vision describe, almost uniformly, a run of missed appointments during a period when they felt fine.

Foot checks come second. Neuropathy means an injury can go unnoticed, and people describe finding a wound days after it happened. Accounts from people who came close to amputation are among the most urgent in these collections, and they nearly all begin with something small.

Kidney function, blood pressure and cholesterol are checked for the same reason: they are silent until they are not. People describe wishing somebody had framed the annual review as protection rather than assessment.

Medication, and the guilt attached to it

A recurring and unhelpful belief in these accounts is that needing medication represents personal failure, and that needing insulin represents total failure.

Contributors describe delaying medication for years to prove they could manage without, and describe the damage that accrued in the meantime. Type 2 diabetes is progressive in most people; requiring more support over time is the expected course of the condition rather than a verdict on effort.

The treatment landscape has also changed considerably. Metformin remains the usual starting point, but NICE guidance now brings other classes in much earlier for people with cardiovascular or kidney risk, and several drug classes used in type 2 diabetes have demonstrated benefits beyond blood glucose. Side effects are worth reporting rather than enduring; people describe abandoning a medication entirely because of an effect that could have been managed by a change of formulation or timing had they mentioned it.

What people say they wish they had known

• That the shame is nearly universal, unearned, and gets in the way of care.
• That HbA1c targets are individual, and comparing yours to a stranger's is meaningless.
• That stress, illness and poor sleep move blood glucose independently of food.
• That remission is real, best evidenced closer to diagnosis, and belongs in a supervised programme rather than a solo experiment.
• That burnout is a recognised part of the condition, not a character flaw.
• That the eye and foot checks matter most in the years when nothing hurts.
• That needing medication, including insulin, is the expected course and not a failure.

Reading the accounts in full

Guidelines tell you what is recommended. They do not tell you what it is like to explain to a colleague why you are not having the cake. Our Diabetes & Blood Sugar shelf gathers fifty first-person accounts in each volume, including Sugar Free Life: Type 2 Diabetes Reversal Stories, The Metformin Diaries: Real User Stories and Catching It Early: Prediabetes Turnaround Stories. For the complications specifically, Keeping Sight: Diabetic Retinopathy Stories, Feeling Again: Diabetic Neuropathy Recovery Stories and Standing Strong: Diabetic Foot Care Stories collect accounts from people further down that road.

Every volume includes a section given over to the accounts that did not resolve well, because a book in which everyone reversed it neatly would be dishonest about the condition.

Sources and further reading

• NICE guideline NG28, Type 2 diabetes in adults: management, updated in 2026, which sets out current treatment sequencing and monitoring.
• NHS England — Type 2 Diabetes Path to Remission Programme.
• The DiRECT trial (Lean et al., The Lancet, 2018; two-year results in The Lancet Diabetes & Endocrinology, 2019), funded by Diabetes UK.
• Your GP, practice nurse or diabetes team, whose targets and treatment plan are set for your circumstances and override anything written here.

Healing Stories Network publishes anthologies of first-person patient testimony. This article describes what people report experiencing. It is companion reading and is not medical advice, diagnosis or treatment. Do not stop, start or change any medication, or begin a very low calorie diet, without your clinical team. Read about who writes and checks our articles.